Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15807 articles
LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling
MET was positively correlated with XIST.
»
11/21/18
Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion
Sortilin targeting represents a potential novel breast cancer therapy.
»
11/20/18
Distinct expression profiles and functions of Kindlins in breast cancer
Kindlin-1 overexpression associated with worse patient outcome.
»
11/26/18
Flavonoids modulate multidrug resistance through wnt signaling in P-glycoprotein overexpressing cell lines
Flavonoids pretreatment significantly induced doxorubicin-mediated arrest at G2/M phase.
»
11/26/18
Acyclic retinoid and angiotensin-II receptor blocker exert a combined protective effect against diethylnitrosamine-induced hepatocarcinogenesis in diabetic OLETF rats
Combining ACR with ARB enhanced the tumor-suppressive effect.
»
11/26/18
Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma
Five of 118 genes, CCDC181, PLAU, S1PR1, ELF3 and KLHDC9, used to construct prognostic risk model.
»
11/26/18
Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?
Serum levels of sodium not indicative of PCa-specific or CV death.
»
11/26/18
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer
Intratumor C/EBP-β LIP induction effectively reduced tumor growth and Pgp expression.
»
11/27/18
Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials
Use of combination agents provide evidence for targeting multiple pathways underlying cachexia.
»
11/27/18
miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling
miR-296-5p disrupted intrahepatic and pulmonary metastasis in vivo.
»
11/29/18
< Prev
Next >